CLINICAL EFFICACY OF ONC201 IN RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA PATIENTS Conference

Arrillaga-Romany, Isabel, Kurz, Sylvia, Tarapore, Rohinton et al. (2021). CLINICAL EFFICACY OF ONC201 IN RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA PATIENTS . NEURO-ONCOLOGY, 23 230-230.

Industry Collaboration

cited authors

  • Arrillaga-Romany, Isabel; Kurz, Sylvia; Tarapore, Rohinton; Lu, Guangrong; Sumrall, Ashley; Butowski, Nicholas; Harrison, Rebecca; DeGroot, John; Chi, Andrew; Shonka, Nicole; Umemura, Yoshie; Odia, Yazmin; Mehta, Minesh; Nghiemphu, Phioanh; Cloughesy, Timothy; Taylor, Lynne; Graber, Jerome; Kilburn, Lindsay; Dixit, Karan; Chen, Clark; Gardner, Sharon; Aguilera, Dolly; MacDonald, Tobey; Cluster, Andrew; Mehta, Kathan; Kheradpour, Albert; Melemed, Allen; Allen, Joshua; Batchelor, Tracy; Lassman, Andrew; Wen, Patrick

sustainable development goals

authors

date/time interval

  • November 18, 2021 -

publication date

  • November 1, 2021

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • MA, Boston

Conference

  • 26th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 230

end page

  • 230

volume

  • 23